AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 74 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,521,000 | +14.9% | 146,146 | -0.1% | 0.00% | 0.0% |
| Q3 2016 | $1,324,000 | +22.7% | 146,351 | +1.4% | 0.00% | +100.0% |
| Q2 2016 | $1,079,000 | -8.3% | 144,308 | +10.5% | 0.00% | -50.0% |
| Q1 2016 | $1,177,000 | -5.5% | 130,600 | +35.4% | 0.00% | 0.0% |
| Q4 2015 | $1,246,000 | +36.3% | 96,451 | +2.0% | 0.00% | +100.0% |
| Q3 2015 | $914,000 | -2.1% | 94,604 | +4.3% | 0.00% | 0.0% |
| Q2 2015 | $934,000 | +273.6% | 90,727 | +303.1% | 0.00% | – |
| Q1 2015 | $250,000 | -6.7% | 22,506 | -2.2% | 0.00% | – |
| Q4 2014 | $268,000 | -47.1% | 23,012 | +0.5% | 0.00% | -100.0% |
| Q3 2014 | $507,000 | -18.8% | 22,900 | +1.9% | 0.00% | 0.0% |
| Q2 2014 | $624,000 | – | 22,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |